National Academies Press: OpenBook

Venture Funding and the NIH SBIR Program (2009)

Chapter: Front Matter

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

VENTURE FUNDING AND THE NIH SBIR PROGRAM

Committee for Capitalizing on Science, Technology, and Innovation: An Assessment of the Small Business Innovation Research Program

Policy and Global Affairs

Charles W. Wessner, Editor

NATIONAL RESEARCH COUNCIL OF THE NATIONAL ACADEMIES

THE NATIONAL ACADEMIES PRESS

Washington, D.C.
www.nap.edu

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

THE NATIONAL ACADEMIES PRESS

500 Fifth Street, N.W. Washington, DC 20001

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the Councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

This study was supported by Contract/Grant No. N01-OD-4-2139 (Task Order #99) between the National Academy of Sciences and the U.S. Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the organizations or agencies that provided support for the project.

International Standard Book Number-13: 978-0-309-12997-8

International Standard Book Number-10: 0-309-12997-4

Limited copies are available from the Policy and Global Affairs Division, National Research Council, 500 Fifth Street, N.W., Washington, DC 20001; 202-334-1529.

Additional copies of this report are available from the

National Academies Press,

500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu.

Copyright 2009 by the National Academy of Sciences. All rights reserved.

Printed in the United States of America

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

THE NATIONAL ACADEMIES

Advisers to the Nation on Science, Engineering, and Medicine


The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.


The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Charles M. Vest is president of the National Academy of Engineering.


The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.


The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M Vest are chair and vice chair, respectively, of the National Research Council.


www.national-academies.org

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Committee for Capitalizing on Science, Technology, and Innovation: An Assessment of the Small Business Innovation Research Program

Chair Jacques S. Gansler (NAE) Roger C. Lipitz Chair in Public Policy and Private Enterprise and Director of the Center for Public Policy and Private Enterprise

School of Public Policy University of Maryland

David B. Audretsch Distinguished Professor and Ameritech Chair of Economic Development Director,

Institute for Development Strategies Indiana University

Gene Banucci Executive Chairman

ATMI, Inc.

Jon Baron Executive Director

Coalition for Evidence-Based Policy

Michael Borrus Founding General Partner

X/Seed Capital

Gail Cassell (IOM) Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases

Eli Lilly and Company

Elizabeth Downing CEO

3D Technology Laboratories

M. Christina Gabriel Director,

Innovation Economy The Heinz Endowments

Trevor O. Jones (NAE) Founder and Chairman

Electrosonics Medical, Inc.

Charles E. Kolb President

Aerodyne Research, Inc.

Henry Linsert, Jr. CEO

Columbia Biosciences Corporation

W. Clark McFadden Partner

Dewey & LeBoeuf, LLP

Duncan T. Moore (NAE) Kingslake Professor of Optical Engineering

University of Rochester

Kent Murphy President and CEO

Luna Innovations

Linda F. Powers Managing Director

Toucan Capital Corporation

Tyrone Taylor President

Capitol Advisors on Technology, LLC

Charles Trimble (NAE) CEO, retired

Trimble Navigation

Patrick Windham President

Windham Consulting

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

PROJECT STAFF

Charles W. Wessner Study Director

David E. Dierksheide Program Officer

Sujai J. Shivakumar Senior Program Officer

Adam H. Gertz Program Associate

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

RESEARCH TEAM

Zoltan Acs

University of Baltimore

Alan Anderson Consultant

Philip A. Auerswald

George Mason University

Robert-Allen Baker

Vital Strategies, LLC

Robert Berger

Robert Berger Consulting, LLC

Grant Black

University of Indiana South Bend

Peter Cahill

BRTRC, Inc.

Dirk Czarnitzki

University of Leuven

Julie Ann Elston

Oregon State University

Irwin Feller

American Association for the Advancement of Science

David H. Finifter

The College of William and Mary

Michael Fogarty

University of Portland

Robin Gaster

Innovation Ecologies

Albert N. Link

University of North Carolina

Rosalie Ruegg

TIA Consulting

Paula E. Stephan

Georgia State University

Andrew Toole

Rutgers University

Nicholas Vonortas

George Washington University

Page viii Cite
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

POLICY AND GLOBAL AFFAIRS

Ad hoc Oversight Board for Capitalizing on Science, Technology, and Innovation: An Assessment of the Small Business Innovation Research Program

Robert M. White (NAE), Chair University Professor Emeritus

Electrical and Computer Engineering Carnegie Mellon University

Anita K. Jones (NAE) Lawrence R. Quarles Professor of Engineering and Applied Science

School of Engineering and Applied Science University of Virginia

Mark B. Myers Senior Vice President, retired

Xerox Corporation

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

4

 

FOCUS ON THE TOP 200 AWARD WINNERS

 

39

   

 4.1  Methodology,

 

39

   

 4.2  Additional Research,

 

40

   

 4.3  Sequencing,

 

40

5

 

OTHER SOURCES OF DATA ON THE PARTICIPATION OF VENTURE-OWNED FIRMS

 

43

   

 5.1  Non-participant Survey,

 

43

   

 5.2  NIH-identified Excluded Firms,

 

46

   

 5.3  Balancing Objectives: A View from Martek’s Experience,

 

47

6

 

COMPARING PROJECT OUTCOMES

 

49

   

 6.1  Caveats,

 

49

   

 6.2  Respondent Pools and Response Rates,

 

50

   

 6.3  Outcomes from Surveys,

 

52

   

 6.4  Firm-level Outcomes from Hoover’s Small Business Database,

 

57

   

 6.5  Conclusions: Outcomes from SBIR Funding,

 

59

7

 

IMPACT OF THE SBA RULING ON THE NIH SBIR PROGRAM: FINDINGS AND RECOMMENDATIONS

 

61

   

 7.1  Main Findings,

 

61

   

 7.2  Recommendations,

 

65

 

 

APPENDIXES

 

 

   

 A  Venture-funded Firms Among the 200 Most Prolific Winners of NIH Phase II Awards 1992-2002

 

71

   

 B  NRC Non-participant Survey

 

76

   

 C  NIH List of Firms Excluded on the Grounds of Venture Capital Ownership

 

80

   

 D  Venture-funded Firms: Data from Hoover’s Small Business Database and VentureSource

 

82

   

 E  Analysis of the Evidence Submitted by BIO

 

92

   

 F  SBA Administrative Ruling on Appeal of Cognetix, Inc.

 

95

   

 G  Letter from Elias A. Zerhouni, Director, National Institutes of Health to Hector V. Barreto, Administrator, U.S. Small Business Administration, June 28, 2005

 

103

   

 H  Testimony by Steven C. Preston, SBA Administrator, to the House Small Business Committee, March 13, 2008

 

107

   

 I  Bibliography

 

112

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Preface

Today’s knowledge-based economy is driven in large part by the nation’s capacity to innovate. One of the defining features of the U.S. economy is a high level of entrepreneurial activity. Entrepreneurs in the United States see opportunities and are willing and able to take on risk to bring new welfare enhancing, wealth generating technologies to the market. Yet, while innovation in areas such as genomics, bioinformatics, and nanotechnology presents new opportunities, converting these ideas into innovations for the market involves substantial challenges.1 The American capacity for innovation can be strengthened by addressing the challenges faced by entrepreneurs. Public-private partnerships are one means to help entrepreneurs bring new ideas to market.2

The Small Business Innovation Research (SBIR) program is one of the largest examples of U.S. public-private partnerships. A premise of the SBIR program is that small businesses are an important font for new ideas, but that they likely will need some support in their early stages as they translate these ideas into innovative products and services for the market. Founded in 1982, SBIR is designed to encourage small business to develop new processes and products and to provide quality research in support of the many missions of the U.S. government. By including qualified small businesses in the nation’s R&D effort, SBIR awards

1

See Lewis M. Branscomb, Kenneth P. Morse, Michael J. Roberts, and Darin Boville, Managing Technical Risk: Understanding Private Sector Decision Making on Early Stage Technology Based Projects, Washington, DC: Department of Commerce/National Institute of Standards and Technology, 2000.

2

For a summary analysis of best practice among U.S. public-private partnerships, see National Research Council, Government-Industry Partnerships for the Development of New Technologies: Summary Report, Charles W. Wessner, ed., Washington, DC: The National Academies Press, 2002.

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

are intended to stimulate innovative new technologies to help agencies meet their missions in many areas including health, the environment, and national defense.

Governments around the world are increasingly adopting SBIR type programs to encourage the creation and growth of innovative firms in their economies. Sweden and Russia have adopted SBIR-type programs. The United Kingdom’s SIRI program is similar in concept. In the Netherlands, a successful pilot SBIR program has led the government to expand its scope across the government. In Asia, Japan, Korea, and Taiwan have adopted the SBIR concept as a part of their respective national innovation strategies. And India has adopted an SBIR type program to advance its biotechnology sector. Other countries are actively adopting SBIR type programs. This level of emulation across national innovation systems is striking and speaks to the common opportunities and challenges addressed by SBIR awards and contracts.

As a part of the 2000 reauthorization of the SBIR program, Congress called for a review of the SBIR programs at the Departments of Defense, the National Institutes of Health, the Department of Energy, the National Aeronautics and Space Administration, and the National Science Foundation.

HR 5667 directed the National Research Council (NRC) to evaluate the quality of research and value to the agency mission of the SBIR program. It called for an assessment of the extent to which SBIR projects achieve some measure of commercialization, as well as an evaluation of the program’s overall economic and non-economic benefits. It also called for additional analysis as required to support specific recommendations in areas such as measuring outcomes for agency strategy and performance, increasing federal procurement of technologies produced by small business, and overall improvements to the SBIR program. These reports are being published by the National Academies Press.

While this study was still in progress, the Small Business Administration issued a policy directive in 2002 that to be eligible for SBIR the small business concern should be “at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, except in the case of a joint venture, where each entity to the venture must be 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States.”3 The effect of this directive has been to exclude innovative small firms in which venture capital firms have a controlling interest from the SBIR program.

To better understand the impact of the SBA exclusion of firms receiving venture funding (resulting in majority ownership), the NRC proposed that the NIH study be extended to include this empirical analysis by the NRC. This report seeks to illuminate the consequences of the SBA ruling excluding majority-owned venture capital firms from participation in SBIR projects.

3

Access the SBA’s 2002 SBIR Policy Directive, Section 3(y) (3) at <http://www.zyn.com/sbir/sbres/sba-pd/pd02-S3.htm>.

Page xiii Cite
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

STATEMENT OF TASK

This report presents the NRC analysis of the effect of the Small Business Administration’s eligibility rules with regard to the majority-owned venture capital participation in the NIH SBIR program. Using data from SBIR awards made from fiscal years 1992 to 2002 and with specific attention to the challenges faced by firms in the biomedical field and employing a combination of surveys and case studies adapted from the Methodology developed as part of the current five-agency analysis,4 the NRC investigated the following questions:

  • Which NIH SBIR participating companies have been or are likely to be excluded from the program as a result of the 2002 rule change on venture capital company ownership?

  • What is the likely impact of the 2002 ruling had it been applied during the 1992-2002 timeframe and what is its probable current impact?

Key variables include the presence and amount of SBIR support, the receipt of venture capital funding or other outside funding, and output measures including those related to commercialization and knowledge generation.

This consensus report contains statistical analysis, case study findings, and also presents the NRC Committee’s findings and recommendations.

ACKNOWLEDGMENTS

On behalf of the National Research Council, we express our appreciation and recognition for the insights, experiences, and perspectives made available by the participants of the overall study’s conferences and meetings, as well as survey respondents and case study interviewees who contributed to elements of this study. We are also very much in debt to officials from the leading departments and agencies. Among the many who provided assistance to this complex study, we are especially in debt to Jo Anne Goodnight, the Program Coordinator for the National Institutes of Health SBIR program, who was instrumental in facilitating this review of the impact of policy directive on the NIH SBIR program.

As the lead member of the Committee’s research staff, Dr. Robin Gaster deserves major recognition for his instrumental role in the research team’s preparation of this report. Sujai Shivakumar also merits thanks for his careful review, edits, analysis, and written contributions which were essential for the preparation of this report. Without their sustained efforts, amidst many other competing priorities, it would not have been possible to prepare this report.

4

National Research Council, An Assessment of the Small Business Innovation Research Program—Project Methodology, Washington, DC: The National Academies Press, 2004. Access at <http://www.nap.edu/catalog.php?record_id=11097>.

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

NATIONAL RESEARCH COUNCIL REVIEW

This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Academies’ Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.

We wish to thank the following individuals for their review of this report: Richard Bendis, National Association of Seed and Venture Funds; Douglas Doerfler, Maxcyte Inc.; David Goldston, Harvard University; Heidi Jacobus, Cybernet Systems; Anu Mittal, United States Government Accountability Office; Carol Nacy, Sequella, Inc.; Michael Rodemeyer, University of Virginia; Donald Siegel, University of Albany; Michael Squillante, Radiation Monitoring Devices, Inc.; and Judith Tanur, Stony Brook University.

Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the conclusions or recommendations, nor did they see the final draft of the report before its release. The review of this report was overseen by Robert White, Carnegie Mellon University. Appointed by the National Academies, he was responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this report rests entirely with the authoring committee and the institution.


Jacques S. Gansler

Charles W. Wessner

Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R1
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R2
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R3
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R4
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R5
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R6
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R7
Page viii Cite
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R8
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R9
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R10
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R11
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R12
Page xiii Cite
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R13
Suggested Citation:"Front Matter." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page R14
Next: Executive Summary »
Venture Funding and the NIH SBIR Program Get This Book
×
Buy Paperback | $34.50 Buy Ebook | $27.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The Small Business Administration issued a policy directive in 2002, the effect of which has been to exclude innovative small firms in which venture capital firms have a controlling interest from the SBIR program. This book seeks to illuminate the consequences of the SBA ruling excluding majority-owned venture capital firms from participation in SBIR projects.

This book is part of the National Research Council's study to evaluate the SBIR program's quality of research and value to the missions of five government agencies. The other books in the series include:

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!